Product Program year 2025 Source: CMS Open Payments

Pristine

Device Vascular/Oncology

PDI 00801741219078

Open in the dashboard

General payments

$75,617

896 payments

Research payments

$0

0 payments

Through program year 2025, $75,617 in general payments and $0 in research payments were reported against Pristine (Vascular/Oncology).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

3 rows
Year Kind Amount Payments
2025 General $9,318 170
2024 General $17,456 343
2023 General $48,843 383

Breakdown

Who paid General payments · program years 2023–2025
  1. Bard Peripheral Vascular, Inc. $68,627 764 payments
  2. Becton, Dickinson and Company $6,990 132 payments
Top recipients General payments · program year 2025
  1. Ahmed Abdel Aal Vascular & Interventional Radiology · Houston, TX $1,209 13% · 2 payments
  2. John Park Vascular Surgery · Omaha, NE $586 6% · 1 payment
  3. Matthew Langenberg Vascular Surgery · Evansville, IN $419 4% · 1 payment
  4. Satyaki Banerjee Nephrology · Albuquerque, NM $194 2% · 14 payments
  5. John Sunderland Diagnostic Radiology · Louisville, KY $173 2% · 2 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Vascular Surgery Surgery $2,297 25% · 24 practitioners
  2. Vascular & Interventional Radiology Radiology $1,858 20% · 18 practitioners
  3. Diagnostic Radiology Radiology $1,408 15% · 18 practitioners
  4. Nephrology Internal Medicine $994 11% · 19 practitioners
  5. Surgery $569 6% · 8 practitioners

The top 5 of 25 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. Texas $1,209 13% · 1 recipient
  2. California $1,082 12% · 24 recipients
  3. New York $1,062 11% · 14 recipients
  4. Kentucky $865 9% · 8 recipients
  5. Maryland $629 7% · 9 recipients

The top 5 of 25 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

896 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record